2010
DOI: 10.1136/jmg.2009.069906
|View full text |Cite
|
Sign up to set email alerts
|

Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes

Abstract: The authors further characterise the 17p13.3 microdeletion and microduplication phenotypic spectrum and describe a smaller critical genomic region allowing identification of candidate genes for the distinctive facial dysmorphism (microdeletions) and autism (microduplications) manifestations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
181
2
3

Year Published

2010
2010
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 143 publications
(201 citation statements)
references
References 36 publications
11
181
2
3
Order By: Relevance
“…As the individuals described in Bruno et al 25 with hand/foot anomalies had microduplications that extended across our critical region, their limb anomalies may represent a subtle skeletal phenotype that, at the most extreme, can manifest as SHFLD. Given the decreased penetrance seen with the microduplications, there is also the possibility that a second genetic locus is involved.…”
Section: Sequence Alignments and Phylogenetic Analysismentioning
confidence: 99%
“…As the individuals described in Bruno et al 25 with hand/foot anomalies had microduplications that extended across our critical region, their limb anomalies may represent a subtle skeletal phenotype that, at the most extreme, can manifest as SHFLD. Given the decreased penetrance seen with the microduplications, there is also the possibility that a second genetic locus is involved.…”
Section: Sequence Alignments and Phylogenetic Analysismentioning
confidence: 99%
“…5 Además, la duplicación de una región en el cromosoma 17p13.3 ha emergido como un nuevo síndrome distintivo (OMIM #613215). 9 L a s c a r a c t e r í s t i c a s f e n o t í p i c a s d e e s t e síndrome incluyen restricción del crecimiento intrauterino (RCIU), retardo del desarrollo psicomotor, hipotonía, dismorfismo craneofacial, braquidactilia, falanges distales acortadas, hallux valgus, de leve a moderado déficit cognitivo, problemas comportamentales pertenecientes a l e s p e c t r o a u t i s t a y , o c a s i o n a l m e n t e , malformaciones cerebrales que afectan el cuerpo calloso, el cerebelo y la fosa posterior. La heterogeneidad fenotípica de este síndrome es consecuencia de las variaciones de tamaño en el segmento duplicado, dadas por diferentes puntos de ruptura, que afectan el contenido génico dentro de este.…”
Section: Figura 3 Cariotipo De La Pacienteunclassified
“…Hasta el momento, han sido reportados 16 pacientes en la literatura médica indexada con duplicaciones de 17p13.3 y sus variantes. [9][10][11] Mediante el uso de la herramienta informática Genoglyphix Genome Browser de Signature Genomics, se identificaron 8 genes (Figura 4) en la región 17p13.2p13.3, correspondiente al segmento duplicado de la paciente. Uno de estos genes, CAMKK1, codifica una proteína quinasa-quinasa dependiente de calcio/calmodulina, que ha sido implicada en la transcripción génica neuronal y la plasticidad sináptica, por lo cual es posible que su sobreexpresión pueda afectar el adecuado desarrollo cerebral.…”
Section: Figura 3 Cariotipo De La Pacienteunclassified
“…To further investigate whether second-site variants are a distinctive feature of a subset of phenotypically variable genomic disorders, we stratified our findings in the case samples according to specific primary variants and observed a nominally significant (P<0.05) enrichment for the presence of at least one additional large variant at a second site for 7 of 72 genomic disorders (as defined by the primary variant), as compared with control samples, including the 15q11.2 (NIPA2) deletion, 12,30 16p11.2 (TBX6) duplication, 15,17 16p12.1 (CDR2) deletion, 21 16p11.2 (SH2B1) distal duplication, 3q29 (DLG1) duplication, 24 17p13.3 (YWHAE) duplication, 31 and 15q23q24 (ETFA) deletion. 1 Repeating the analysis after removal of very large copy-number variants (>30 Mb) still resulted in significance for the enrichment of second-site variants for the 7 disorders (Fig.…”
Section: Enrichment For Second-site Variantsmentioning
confidence: 99%